Clinical Trial Update: A Clinical Study of AK120 in Adolescents With Moderate-to-severe Atopic Dermatitis [Phase 3]

View source ↗

Summary

A Phase 3 clinical study evaluating AK120 in adolescents with moderate-to-severe Atopic Dermatitis is not yet recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Atopic Dermatitis

Drugs mentioned

• AK120

Snippet

Sponsor: Akeso | Conditions: Atopic Dermatitis | Phase 3 | Status: NOT_YET_RECRUITING